Effects of Pre-emptive Scalp Infiltration With Low-dose Ketorolac and Ropivacaine for Postoperative Pain
Status:
Not yet recruiting
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
The PAINLESS study is a single-center, prospective, randomized, open-label, blinded-endpoint
(PROBE) controlled clinical pilot study to compare the efficacy and safety of pre-emptive
scalp infiltration with ropivacaine plus ketorolac and ropivacaine alone for postoperative
pain relief in adults undergoing elective supratentorial craniotomies.